Sorted By:

Relevance


New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.orgwww.FromHopetoCures.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA
http://www.phrma.org/press-release/paul-a-aines-named-phrma-executive-vice-president-and-chief-financial-officer-del-persinger-to-retire

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/new-reports-highlight-increasing-global-competition-in-biopharmaceutical-randd-posing-significant-challenges-to-future-u-s-standing

PhRMA Foundation Launches New Web Platform

PhRMA  |  Blog Post

Later this year, we’ll be launching educational modules for health care professionals developed in partnership with the National Institutes of Health (NIH) and the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
http://catalyst.phrma.org/phrma-foundation-launches-new-web-platform

Rep. Clyburn among speakers at “Research in Your Backyard” press conference

PhRMA  |  Press Release

“Clinical trials provide an important message of hope for patients who seek new treatment for unmet medical needs.
http://www.phrma.org/press-release/rep-clyburn-among-speakers-at-research-in-your-backyard-press-conference

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-therapeutic-and-preventative-vaccines-in-development

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

PhRMA  |  Blog Post

Read more about the PPVF initiative in a Health Affairs blog post from Avalere and FasterCures here.
http://catalyst.phrma.org/icymi-avalere-and-fastercures-develop-new-value-framework-from-patient-perspective

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros cambios en el estilo de vida, así como los medicamentos que a diario deben tomar para manejar los niveles de glucosa en la sangre.
http://www.phrma.org/report/medicamentos-en-desarrollo-para-la-diabetes

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

PhRMA  |  Blog Post

Learn more at www.phrma.org/cost.
http://catalyst.phrma.org/icymi-ims-institute-branded-net-medicine-price-increases-lowest-in-past-five-years

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“Helping patients and addressing the burden of disease is what drives the men and women of this industry every single day,” said Bradway.
http://www.phrma.org/press-release/phrma-board-of-directors-elects-new-officers-welcomes-new-member-company

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

You can find information on events in other countries on the global Rare Disease Day website.
http://catalyst.phrma.org/rarepov-conversation-generates-strong-enthusiasm-for-rare-disease-day-on-february-28th

Study finds actual cost of 14 new medicines is billions less than predicted

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to deliver innovative treatments to patients here.
http://catalyst.phrma.org/study-finds-actual-cost-of-14-new-medicines-is-billions-less-than-predicted

ICYMI: New study shows medicines advance life expectancy for HIV patients

PhRMA  |  Blog Post

Just in the last 10 years, 15 new medicines for HIV/AIDS were approved by the U.S.
http://catalyst.phrma.org/icymi-new-study-shows-medicines-advance-life-expectancy-for-hiv-patients

New Medicine Approvals 2015 Report

PhRMA  |  Report

The new medicines approved by the FDA in 2015 demonstrate the tireless work of America’s biopharmaceutical researchers and scientists to deliver on the promise of science.
http://www.phrma.org/report/new-medicine-approvals-2015-report

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

PhRMA  |  Blog Post

Visit .com/?
http://catalyst.phrma.org/video-phrma-ceo-joins-fox-business-anchor-neil-cavuto-to-discuss-personal-connection-to-value-of-innovation-and-white-house-meeting

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

New treatments alleviating common side effects of the disease have also become available allowing for better disease management.
http://catalyst.phrma.org/celebrating-tremendous-advances-in-hiv/aids-on-national-youth-hiv/aids-awareness-day

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

PhRMA  |  Press Release

While new approvals in recent years represent significant advances for patients, biopharmaceutical research companies are committed to continuing to seek new cancer treatments and potential cures for America’s patients.
http://www.phrma.org/press-release/new-report-shows-more-than-240-immuno-oncology-treatments-in-development-for-patients-with-cancer

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org

New Report: Many Exchange Plans Burden the Most Vulnerable Patients with High Out-of-Pocket Costs for Vital Medicines; Patients left with limited access

PhRMA  |  Press Release

Eric Hargis, Colon Cancer Alliance CEO, stated, “Colorectal cancer is the second leading cause of cancer deaths in America; however, thanks to the development of personalized therapies and other innovative treatments the prognosis for colorectal cancer patients is the best it has ever been and today there are more than one million survivors in the United States.  
http://www.phrma.org/press-release/new-report-many-exchange-plans-burden-the-most-vulnerable-patients-with-high-out-of-pocket-costs-for-vital-medicines-patients-left-with-limited-access

Cost of mental illness underscores need for new treatments

PhRMA  |  Blog Post

Learn more in the 2016 “Medicines in Development for Mental Illnesses” report, and see the full list of medicines currently in development to treat mental illnesses.
http://catalyst.phrma.org/cost-of-mental-illness-underscores-need-for-new-treatments

Yep, Obamacare Costs a Fortune

Access Better Coverage  |  From Our Network

More important, and potentially worrisome for the law's defenders: Average deductibles for silver plans (the most popular type of exchange coverage) are about three times as high as on employer plans.
http://www.accessbettercoverage.org/social-news/yep-obamacare-costs-a-fortune

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

Check out an interview with Marisa Dolled-Filhart, Ph.D., director of pathology and companion diagnostics at Merck, on her work as part of the oncology team.
http://catalyst.phrma.org/world-cancer-day-reflecting-on-progress-and-hope-for-the-future-in-cancer-treatment

New Questions About Why More Women Than Men Have Alzheimer's

From Hope To Cures  |  From Our Network

But it wasn't until after her own diagnosis a few years ago that Shives looked up the gender statistics.
http://www.fromhopetocures.org/new-questions-about-why-more-women-than-men-have-alzheimers

A Sea Change in Treating Heart Attacks

From Hope To Cures  |  From Our Network

At Yale-New Haven Hospital, where half the patients used to have to wait at least 150 minutes before their arteries were opened, the median time is now 57 minutes.
http://www.fromhopetocures.org/a-sea-change-in-treating-heart-attacks

You have reviewed the first 100 results out of 1960. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next